Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients

Many patients undergoing chemotherapy experience severe taste disruptions that make eating a challenge at a time when maintaining good nutrition is extremely important. Now, researchers report that they have identified the pathway responsible for taste changes among users of chemotherapy drugs that treat basal cell carcinoma.

Read the whole article on Science Daily

More from Science Daily